39 related articles for article (PubMed ID: 10566796)
21. WHO activities to assure the quality of biological products.
Magrath D
Dev Biol Stand; 1993; 81():265-8. PubMed ID: 8174812
[No Abstract] [Full Text] [Related]
22. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
23. Methods of endotoxin removal from biological preparations: a review.
Magalhães PO; Lopes AM; Mazzola PG; Rangel-Yagui C; Penna TC; Pessoa A
J Pharm Pharm Sci; 2007; 10(3):388-404. PubMed ID: 17727802
[TBL] [Abstract][Full Text] [Related]
24. The external quality assessment schemes in Thailand.
Opartkiattikul N; Bejrachandra S
Rinsho Byori; 2002 Feb; 50(2):121-5. PubMed ID: 11925846
[TBL] [Abstract][Full Text] [Related]
25. Biologicals: test procedures available to assess components and products, with limitations.
Lee AM
Rev Sci Tech; 1995 Dec; 14(4):1073-82. PubMed ID: 8639947
[TBL] [Abstract][Full Text] [Related]
26. Future activities: ECVAM and the quality control of biologicals.
Cussler K; Halder M; Hendriksen C
Altern Lab Anim; 2002 Dec; 30 Suppl 2():225-6. PubMed ID: 12513681
[TBL] [Abstract][Full Text] [Related]
27. Relationship between nature and source of risk and process validation.
Berthold W; Werz W; Walter JK
Dev Biol Stand; 1996; 88():59-71. PubMed ID: 9119164
[No Abstract] [Full Text] [Related]
28. Risk analysis for veterinary biologicals released into the environment.
Silva SV; Samagh BS; Morley RS
Rev Sci Tech; 1995 Dec; 14(4):1043-59. PubMed ID: 8639945
[TBL] [Abstract][Full Text] [Related]
29. Practical computer validation for pharmaceutical laboratories.
McDowall RD
J Pharm Biomed Anal; 1995 Dec; 14(1-2):13-22. PubMed ID: 8833962
[TBL] [Abstract][Full Text] [Related]
30. [Theoretical bases and experimental verifications in using cell cultures in developing new quality assessment and standardization criteria for medical immunobiological preparations].
Chervonskaia GP; Kravchenko AT
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):84-91. PubMed ID: 3529756
[No Abstract] [Full Text] [Related]
31. Validation and acceptance of new and revised tests: a flexible but transparent process.
Zeiger E
Toxicol Lett; 2003 Apr; 140-141():31-5. PubMed ID: 12676448
[TBL] [Abstract][Full Text] [Related]
32. Reference standards for vaccine-producing laboratories.
Castle P
Rev Sci Tech; 1998 Aug; 17(2):585-91. PubMed ID: 9713898
[TBL] [Abstract][Full Text] [Related]
33. Risk assessment related to veterinary biologicals: side-effects in target animals.
Martinod S
Rev Sci Tech; 1995 Dec; 14(4):979-89. PubMed ID: 8639966
[TBL] [Abstract][Full Text] [Related]
34. Present systems and future needs for risk assessment of veterinary biologicals in Australia: the perspective of the regulator.
Doyle KA
Rev Sci Tech; 1995 Dec; 14(4):1157-70. PubMed ID: 8639953
[TBL] [Abstract][Full Text] [Related]
35. Validation of tests methods in the quality control of biologicals.
Hendriksen CF
Dev Biol Stand; 1999; 101():217-21. PubMed ID: 10566796
[TBL] [Abstract][Full Text] [Related]
36. A 4R concept for the safety testing of immunobiologicals.
Cussler K
Dev Biol Stand; 1999; 101():121-6. PubMed ID: 10566784
[TBL] [Abstract][Full Text] [Related]
37. [Validation and regulatory acceptance of alternative methods for toxicity evaluation].
Ohno Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2004; (122):1-9. PubMed ID: 15940895
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
39. Validation of molecular-diagnostic techniques in the parasitological laboratory.
Conraths FJ; Schares G
Vet Parasitol; 2006 Mar; 136(2):91-8. PubMed ID: 16414191
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
